Use of Tl-201 over Tc-99m linked to higher costs, future testing

08/5/2013 | CardiovascularBusiness.com

A Canadian study found that switching from isotope technetium-99m to thallium-201 may raise long-term costs, testing and radiation dose. Researchers at the University of Ottawa Heart Institute collected data from 7,402 consecutive patients who underwent SPECT MPI before, during and after the institute's substitution of Tl-201 during a shortage of Tc-99m. False positives were higher with Tl-201, and the isotope "was associated with a significant increase (9.8%) in downstream resource utilization amounting to a cost increase of $74.25/patient," researchers said.

View Full Article in:

CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC